title: Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial.
abstract: OBJECTIVE
  To evaluate whether selective digestive decontamination (SDD) reduces mortality from any cause, and the incidence of pneumonia among patients with severe burns.
  
  
  BACKGROUND
  SDD is a prophylactic strategy to reduce infectious morbidity and mortality in critically ill patients. Two meta-analyses and a recent randomized controlled trial demonstrated a mortality reduction varying between 20% and 40%. But this technique has never been properly evaluated in severely burned patients.
  
  
  METHODS
  The design of this single-center trial was randomized, double blind, placebo controlled. Patients with burns > or =20% of total body surface and/or suspected inhalation injury were enrolled and assigned to receive SDD or placebo for the total duration of treatment in the burn intensive care unit (ICU).
  
  
  RESULTS
  One hundred seventeen patients were randomized and 107 were analyzed (53 in the SDD group and 54 in the placebo group). The ICU mortality was 27.8% in the placebo group and 9.4% in the SDD group in the burn ICU. Treatment with SDD was associated with a significant reduction in mortality both in the burn ICU (risk ratio 0.25; 95% CI 0.08 to 0.76) and in the hospital (risk ratio 0.28; 95% CI 0.10 to 0.80), following adjustment for predicted mortality. The incidence of pneumonia was significantly higher in the placebo group: 30.8 and 17.0 pneumonias per 1000 ventilation days (P = 0.03) in placebo and SDD group, respectively.
  
  
  CONCLUSIONS
  Treatment with SDD reduces mortality and pneumonia incidence in patients with severe burns.
authors.affiliation: Department of Critical Care Medicine, Hospital Universitario de Getafe, Madrid, Spain. mcal@ucigetafe.com
authors.forename: Miguel A
authors.initials: MA
authors.lastname: de La Cal
authors.forename: Enrique
authors.initials: E
authors.lastname: Cerdá
authors.forename: Paloma
authors.initials: P
authors.lastname: García-Hierro
authors.forename: Hendrick K F
authors.initials: HK
authors.lastname: van Saene
authors.forename: Dulce
authors.initials: D
authors.lastname: Gómez-Santos
authors.forename: Eva
authors.initials: E
authors.lastname: Negro
authors.forename: José Angel
authors.initials: JA
authors.lastname: Lorente
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents; D002056:Burns / Q000382:microbiology* / Q000401:mortality / Q000628:therapy; D016638:Critical Illness; D003428:Cross Infection / Q000517:prevention & control; D003666:Decontamination; D004311:Double-Blind Method; D004359:Drug Therapy, Combination / Q000008:administration & dosage*; D005260:Female; D041981:Gastrointestinal Tract / Q000382:microbiology*; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000517:prevention & control; D018805:Sepsis / Q000517:prevention & control; D015996:Survival Rate; D014552:Urinary Tract Infections / Q000517:prevention & control
chemical_list: D000900:Anti-Bacterial Agents
references.citation: Surgery. 1978 May;83(5):523-7
references.pmid: 347612
references.citation: Intensive Care Med. 1996 May;22(5):387-94
references.pmid: 8796388
references.citation: Crit Care Med. 1997 Jan;25(1):63-71
references.pmid: 8989178
references.citation: Ann Surg. 1987 Jan;205(1):82-7
references.pmid: 3800465
references.citation: Lancet. 1992 Jul 4;340(8810):5-9
references.pmid: 1351620
references.citation: N Engl J Med. 1998 Feb 5;338(6):362-6
references.pmid: 9449729
references.citation: Am J Respir Crit Care Med. 1994 Aug;150(2):565-9
references.pmid: 8049849
references.citation: J Antimicrob Chemother. 1994 Jul;34(1):139-48
references.pmid: 7961200
references.citation: Lancet. 2003 Sep 27;362(9389):1011-6
references.pmid: 14522530
references.citation: J Hosp Infect. 1996 May;33(1):1-12
references.pmid: 8738198
references.citation: J Trauma. 1994 Oct;37(4):655-9
references.pmid: 7932899
references.citation: Burns. 2001 Aug;27(5):439-45
references.pmid: 11451595
references.citation: Crit Care Med. 1990 Mar;18(3):264-9
references.pmid: 2302949
references.citation: Chest. 2001 Apr;119(4):1160-5
references.pmid: 11296184
references.citation: J Trauma. 1992 May;32(5):570-5
references.pmid: 1588644
references.citation: N Engl J Med. 1992 Feb 27;326(9):594-9
references.pmid: 1734249
references.citation: Clin Infect Dis. 1995 Apr;20(4):861-7
references.pmid: 7795086
references.citation: J Burn Care Rehabil. 1998 Sep-Oct;19(5):386-9
references.pmid: 9789171
references.citation: J Hosp Infect. 2004 Mar;56(3):175-83
references.pmid: 15003664
references.citation: Am J Infect Control. 1988 Jun;16(3):128-40
references.pmid: 2841893
references.citation: Am J Infect Control. 2002 Nov;30(7):391-9
references.pmid: 12410215
references.citation: J Burn Care Rehabil. 1990 Nov-Dec;11(6):575-80
references.pmid: 2286616
references.citation: Arch Surg. 1999 Feb;134(2):170-6
references.pmid: 10025458
references.citation: Chest. 1997 Mar;111(3):676-85
references.pmid: 9118708
references.citation: Burns. 2003 Feb;29(1):15-24
references.pmid: 12543040
references.citation: Am J Respir Crit Care Med. 2000 Jul;162(1):119-25
references.pmid: 10903230
references.citation: Ann Intern Med. 1994 Mar 1;120(5):389-95
references.pmid: 8304656
references.citation: J Trauma. 1997 Apr;42(4):687-94
references.pmid: 9137259
references.citation: Clin Plast Surg. 1974 Oct;1(4):693-703
references.pmid: 4609676
references.citation: Cochrane Database Syst Rev. 2004;(1):CD000022
references.pmid: 14973945